July 26, 2017 12:52 AM ET

Pharmaceuticals

Company Overview of OAO Scientific-Production Concern Eskom

Company Overview

OAO Scientific-Production Concern Eskom manufactures drugs based on the technology of designing liposomal Nanocontainers. The company is based in Stavropol, Russian Federation.

Stavropol,  

Russia

Key Executives for OAO Scientific-Production Concern Eskom

General Director
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
Aknol Europe
Alfarm, Ooo Europe
Angelico Pharmaceuticals Europe
AO Medisorb Europe
Biomed Im. I.I. Mechnikova, AO Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OAO Scientific-Production Concern Eskom, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.